Discuss This Disease

4 free views remaining today

neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies

Description

Neurodevelopmental Disorder with Brain Abnormalities, Poor Growth, and Dysmorphic Facies (NEDBGF) is a rare genetic syndrome that affects various aspects of development.

  • Autosomal Recessive Inheritance: NEDBGF is inherited in an autosomal recessive pattern, meaning that the disorder occurs when an individual inherits two copies of the mutated gene, one from each parent [1][2].
  • Global Developmental Delay: Individuals with NEDBGF often experience global developmental delay, which can manifest as delayed speech and language development, impaired intellectual development, and poor or absent speech [3][4].
  • Structural Brain Abnormalities: The disorder is characterized by structural brain anomalies, including corpus callosum abnormalities [5].
  • Dysmorphic Facies: Individuals with NEDBGF often exhibit dysmorphic facies, which can include features such as a small head size, a flat face, and other distinctive facial characteristics [6][7].
  • Poor Growth: Poor growth is another characteristic feature of NEDBGF, which can manifest as short stature or failure to thrive [8].

Overall, NEDBGF is a complex disorder that affects multiple aspects of development, including cognitive, motor, and physical development.

Additional Characteristics

  • Global Developmental Delay
  • Autosomal Recessive Inheritance
  • Poor Growth
  • Dysmorphic Facies
  • Structural Brain Abnormalities

Signs and Symptoms

Based on the search results, here are the signs and symptoms of neurodevelopmental disorders with brain abnormalities, poor growth, and dysmorphic facies:

  • Poor feeding: Patients often show poor feeding habits [3].
  • Poor overall growth: Children with these disorders may experience poor overall growth, which can be a significant concern for parents and caregivers [3].
  • Dysmorphic facial features: Individuals with neurodevelopmental disorders with brain abnormalities, poor growth, and dysmorphic facies often exhibit distinctive facial features that are not typical of the general population [4].
  • Structural brain abnormalities: These disorders are characterized by structural brain abnormalities, which can affect various aspects of cognitive and motor function [4].
  • Cortical visual impairment: Some individuals with these disorders may experience cortical visual impairment, which can impact their ability to process visual information [6].
  • Global developmental delay: Children with neurodevelopmental disorders with brain abnormalities, poor growth, and dysmorphic facies often exhibit global developmental delays, which can affect multiple areas of development, including cognitive, motor, and language skills [6].
  • Hypertonia and spasticity: Some individuals with these disorders may experience hypertonia (increased muscle tone) or spasticity (muscle stiffness), particularly in the limbs [4, 6].

It's essential to note that each individual with a neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies can present differently, and not all symptoms may be present in every case. A comprehensive evaluation by a qualified healthcare professional is necessary for an accurate diagnosis and treatment plan.

References: [3] - Context result 3 [4] - Context result 4 [6] - Context result 6

Additional Symptoms

  • **Poor overall growth**
  • **Dysmorphic facial features**
  • **Structural brain abnormalities**
  • **Cortical visual impairment**
  • **Global developmental delay**
  • poor feeding
  • spasticity

Diagnostic Tests

Diagnostic Tests for Neurodevelopmental Disorder with Brain Abnormalities, Poor Growth, and Dysmorphic Facies

The diagnostic tests for neurodevelopmental disorders with brain abnormalities, poor growth, and dysmorphic facies (NEDBGF) are crucial in identifying the underlying genetic causes of these conditions. Here are some of the diagnostic tests that may be used:

  • Chromosomal Microarray (CMA): This is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies [3]. CMA can detect copy number variations (CNVs) in the genome, which can contribute to NEDBGF.
  • Fragile X Testing: Fragile X syndrome is a genetic disorder that affects brain development and can lead to NEDBGF. Fragile X testing involves analyzing the FMR1 gene for repeat expansions [8].
  • Karyotyping: Karyotyping is a cytogenetic test that examines the number and structure of chromosomes. It can help identify chromosomal abnormalities, such as deletions or duplications, that may contribute to NEDBGF [8].
  • Genome Techniques: Genome techniques, such as chromosomal microarray (CMA), are increasingly being used to diagnose neurodevelopmental disorders in low- and middle-income countries [10].

Other Diagnostic Tests

In addition to the above tests, other diagnostic tests that may be used to diagnose NEDBGF include:

  • ADNP Gene Analysis: The ADNP gene has been associated with NEDBGF. Analyzing this gene can help identify mutations that contribute to the condition [5].
  • Clinical Evaluation: A comprehensive clinical evaluation is essential in diagnosing NEDBGF. This includes a detailed medical history, physical examination, and assessment of developmental milestones.

References

[1] Context 3 [2] Context 8 [3] Context 3 [4] Context 9 [5] Context 5 [6] Context 6 [7] Context 7 [8] Context 8 [9] Context 9 [10] Context 10

Additional Diagnostic Tests

  • Karyotyping
  • Chromosomal Microarray (CMA)
  • Fragile X Testing
  • Genome Techniques
  • ADNP Gene Analysis

Treatment

Pharmacotherapy for Neurodevelopmental Disorders

The treatment of neurodevelopmental disorders (NDDs) with brain abnormalities, poor growth, and dysmorphic facies is a complex issue. While there are no specific treatments that can cure these conditions, various pharmacotherapies have been explored to manage their symptoms.

  • Growth Hormone Treatment: Growth hormone treatment has been shown to improve growth outcomes in children with NDDs (NEDDFL) [8].
  • Epilepsy Management: Epilepsy is a common symptom in many NDDs, and controlling early epilepsy is crucial for slowing the progression of neurological impairment and restoring normal development [11].
  • Targeting Multiple Endophenotypes: To improve pharmacotherapy and drug discovery for NDDs, it's essential to target multiple endophenotypes, disentangle genetic/epigenetic factors, and consider potential developmental/trophic roles of brain neurotransmitters [15].

Important Considerations

While these treatments may provide some benefits, it's crucial to note that:

  • Individualized Treatment Plans: Each individual with an NDD is unique, and treatment plans should be tailored to their specific needs.
  • Multidisciplinary Approach: A multidisciplinary approach involving healthcare professionals from various specialties (e.g., neurology, psychology, genetics) is essential for comprehensive care.

References

[8] - The effect of growth hormone treatment in children with NEDDFL [context 8] [11] - Studies on the control of early epilepsy and its impact on neurological impairment [context 11] [15] - Recommendations for improving pharmacotherapy and drug discovery for NDDs [context 15]

Please let me know if you need any further information.

Recommended Medications

  • Growth Hormone Treatment
  • Epilepsy Management
  • Targeting Multiple Endophenotypes

💊 Drug information is sourced from ChEBI (Chemical Entities of Biological Interest) database. Always consult with a healthcare professional before starting any medication. Click on any medication name for detailed information.

Differential Diagnosis

The differential diagnosis for neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies (NEDBGF) is a complex process that involves ruling out other conditions that may present with similar symptoms. Based on the search results, here are some potential differential diagnoses to consider:

  • ADNP syndrome: Also known as Helsmoortel-Van Der Aa syndrome, this genetic disorder affects brain development and can lead to a wide range of challenges, including developmental delay, intellectual disability, and dysmorphic facial features [4].
  • CHD8-related neurodevelopmental disorder with overgrowth (CHD8-NDD): This condition is characterized by increased head circumference, poor growth, and dysmorphic facies, among other symptoms. It's essential to consider this diagnosis in cases where NEDBGF is suspected [13].
  • Malformations of cortical development (MCDs): These neurodevelopmental disorders result from abnormal development of the cerebral cortex in utero and can present with similar symptoms to NEDBGF, including poor growth and dysmorphic facies [14].
  • Neurodevelopmental disorder with hypotonia and dysmorphic facies (NEDHYDF): This condition is characterized by global developmental delay and hypotonia apparent from birth, which may be similar to the symptoms presented in NEDBGF [2].

It's crucial to note that these differential diagnoses are not exhaustive, and a comprehensive evaluation by a qualified healthcare professional is necessary to determine the most likely diagnosis.

References:

[4] ADNP syndrome: Also known as Helsmoortel-Van Der Aa syndrome, this genetic disorder affects brain development and can lead to a wide range of challenges, including developmental delay, intellectual disability, and dysmorphic facial features. [13] CHD8-related neurodevelopmental disorder with overgrowth (CHD8-NDD): This condition is characterized by increased head circumference, poor growth, and dysmorphic facies, among other symptoms. [14] Malformations of cortical development (MCDs): These neurodevelopmental disorders result from abnormal development of the cerebral cortex in utero and can present with similar symptoms to NEDBGF, including poor growth and dysmorphic facies. [2] Neurodevelopmental disorder with hypotonia and dysmorphic facies (NEDHYDF): This condition is characterized by global developmental delay and hypotonia apparent from birth.

Additional Information

rdf-schema#domain
https://w3id.org/def/predibionto#has_symptom_3934
owl#annotatedSource
t357827
oboInOwl#hasOBONamespace
disease_ontology
oboInOwl#id
DOID:0081099
core#notation
DOID:0081099
oboInOwl#hasDbXref
MIM:615286
oboInOwl#hasExactSynonym
autosomal recessive mental retardation 36
rdf-schema#label
neurodevelopmental disorder with brain abnormalities, poor growth, and dysmorphic facies
IAO_0000115
An autosomal recessive intellectual developmental disorder that is characterized by global developmental delay with delayed walking, impaired intellectual development, and speech delay apparent from infancy or early childhood and that has_material_basis_in homozygous mutation in the ADAT3 gene on chromosome 19p13.
rdf-schema#subClassOf
http://purl.obolibrary.org/obo/DOID_0060308
22-rdf-syntax-ns#type
http://www.w3.org/2002/07/owl#Class

Medical Disclaimer: The information provided on this website is for general informational and educational purposes only.

It is not intended to be a substitute for professional medical advice, diagnosis, or treatment. Always seek the advice of your physician or other qualified healthcare provider with questions about your medical condition.